Next Generation Sequencing Market

1. Executive Summary
    1.1. Key Market Insights  

2. Introduction            
    2.1. Study Objectives        
    2.2. Market Definition        
           2.2.1. Market Covered    
           2.2.2. Regional Coverage    
           2.2.3. Study Years & Currency    
    2.3. Market Stakeholders        
    2.4. Key Questions this Study will Answer        
    2.5. GMI Research’s Approach & Methodology  
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Next-Generation Sequencing Market- Overview            
    3.1. Introduction         
    3.2. Market Segmentation        
    3.3. Value Chain Analysis        
    3.4. Market Drivers        
    3.5. Market Restraints        
    3.6. Market Trends      

4. Global Next-Generation Sequencing Market Revenue Forecast till 2030     

5. Global Next-Generation Sequencing Market by Technology Revenue Forecast till 2030            
    5.1. Targeted Sequencing 
    5.2. Resequencing

6. Global Next-Generation Sequencing Market by Application Revenue Forecast till 2030            
    6.1. Oncology
    6.2. Clinical Investigation
    6.3. Reproductive Health
    6.4. HLA Typing/ Immune System Monitoring
    6.5. Metagenomics
    6.6. Epidemiology
    6.7. Drug Development

7. Global Next-Generation Sequencing Market by Workflow Revenue Forecast till 2030            
    7.1. Pre-Sequencing
    7.2. Sequencing
    7.3. NGS Data Analysis

8. Global Next-Generation Sequencing Market by End-Use Revenue Forecast till 2030            
    8.1. Academic Research
    8.2. Clinical Research
    8.3. Hospitals and Clinics
    8.4. Pharma and Biotech Entities
    8.5. Other Users

9. Global Next-Generation Sequencing Market by Region Forecast till 2030
    9.1. North America Next-Generation Sequencing Market Revenue Forecast till 2030 
    (Option 1: As a part of the free 25% customization)
           9.1.1. North America Next-Generation Sequencing Market by Technology
                     9.1.1.1. Targeted Sequencing 
                     9.1.1.2. Resequencing
           9.1.2. North America Next-Generation Sequencing Market by Application
                     9.1.2.1. Oncology
                     9.1.2.2. Clinical Investigation
                     9.1.2.3. Reproductive Health
                     9.1.2.4. HLA Typing/ Immune System Monitoring
                     9.1.2.5. Metagenomics
                     9.1.2.6. Epidemiology
                     9.1.2.7. Drug Development
           9.1.3. North America Next-Generation Sequencing Market by Workflow
                     9.1.3.1. Pre-Sequencing
                     9.1.3.2. Sequencing
                     9.1.3.3. NGS Data Analysis
           9.1.4. North America Next-Generation Sequencing Market by End-Use
                     9.1.4.1. Academic Research
                     9.1.4.2. Clinical Research
                     9.1.4.3. Hospitals and Clinics
                     9.1.4.4. Pharma and Biotech Entities
                     9.1.4.5. Other Users
           9.1.5. US Next-Generation Sequencing Market All-Up
           9.1.6. Canada Next-Generation Sequencing Market All-Up
    9.2. Europe Next-Generation Sequencing Market Revenue Forecast till 2030 
    (Option 2: As a part of the free 25% customization)
           9.2.1. Europe Next-Generation Sequencing Market by Technology
                     9.2.1.1. Targeted Sequencing 
                     9.2.1.2. Resequencing
           9.2.2. Europe Next-Generation Sequencing Market by Application
                     9.2.2.1. Oncology
                     9.2.2.2. Clinical Investigation
                     9.2.2.3. Reproductive Health
                     9.2.2.4. HLA Typing/ Immune System Monitoring
                     9.2.2.5. Metagenomics
                     9.2.2.6. Epidemiology
                     9.2.2.7. Drug Development
           9.2.3. Europe Next-Generation Sequencing Market by Workflow
                     9.2.3.1. Pre-Sequencing
                     9.2.3.2. Sequencing
                     9.2.3.3. NGS Data Analysis
           9.2.4. Europe Next-Generation Sequencing Market by End-Use
                     9.2.4.1. Academic Research
                     9.2.4.2. Clinical Research
                     9.2.4.3. Hospitals and Clinics
                     9.2.4.4. Pharma and Biotech Entities
                     9.2.4.5. Other Users
           9.2.5. UK Next-Generation Sequencing Market All-Up
           9.2.6. Germany Next-Generation Sequencing Market All-Up
           9.2.7. France Next-Generation Sequencing Market All-Up
           9.2.8. Spain Next-Generation Sequencing Market All-Up
           9.2.9. Rest of Europe Next-Generation Sequencing Market All-Up
    9.3. Asia-Pacific Next-Generation Sequencing Market Revenue Forecast till 2030 
    (Option 3: As a part of the free 25% customization) 
           9.3.1. Asia-Pacific Next-Generation Sequencing Market by Technology
                     9.3.1.1. Targeted Sequencing 
                     9.3.1.2. Resequencing
           9.3.2. Asia-Pacific Next-Generation Sequencing Market by Application
                     9.3.2.1. Oncology
                     9.3.2.2. Clinical Investigation
                     9.3.2.3. Reproductive Health
                     9.3.2.4. HLA Typing/ Immune System Monitoring
                     9.3.2.5. Metagenomics
                     9.3.2.6. Epidemiology
                     9.3.2.7. Drug Development
           9.3.3. Asia-Pacific Next-Generation Sequencing Market by Workflow
                     9.3.3.1. Pre-Sequencing
                     9.3.3.2. Sequencing
                     9.3.3.3. NGS Data Analysis
           9.3.4. Asia-Pacific Next-Generation Sequencing Market by End-Use
                     9.3.4.1. Academic Research
                     9.3.4.2. Clinical Research
                     9.3.4.3. Hospitals and Clinics
                     9.3.4.4. Pharma and Biotech Entities
                     9.3.4.5. Other Users
           9.3.5. China Next-Generation Sequencing Market All-Up
           9.3.6. India Next-Generation Sequencing Market All-Up
           9.3.7. Japan Next-Generation Sequencing Market All-Up
           9.3.8. Rest of APAC Next-Generation Sequencing Market All-Up
    9.4. RoW Next-Generation Sequencing Market Revenue Forecast till 2030
    (Option 4: As a part of the free 25% customization)  
           9.4.1. RoW Next-Generation Sequencing Market by Technology
                     9.4.1.1. Targeted Sequencing 
                     9.4.1.2. Resequencing
           9.4.2. RoW Next-Generation Sequencing Market by Application
                     9.4.2.1. Oncology
                     9.4.2.2. Clinical Investigation
                     9.4.2.3. Reproductive Health
                     9.4.2.4. HLA Typing/ Immune System Monitoring
                     9.4.2.5. Metagenomics
                     9.4.2.6. Epidemiology
                     9.4.2.7. Drug Development
           9.4.3. RoW Next-Generation Sequencing Market by Workflow
                     9.4.3.1. Pre-Sequencing
                     9.4.3.2. Sequencing
                     9.4.3.3. NGS Data Analysis
           9.4.4. RoW Next-Generation Sequencing Market by End-Use
                     9.4.4.1. Academic Research
                     9.4.4.2. Clinical Research
                     9.4.4.3. Hospitals and Clinics
                     9.4.4.4. Pharma and Biotech Entities
                     9.4.4.5. Other Users
           9.4.5. Brazil Next-Generation Sequencing Market All-Up
           9.4.6. South Africa Next-Generation Sequencing Market All-Up
           9.4.7. Saudi Arabia Next-Generation Sequencing Market All-Up
           9.4.8. UAE Next-Generation Sequencing Market All-Up
           9.4.9. Rest of world (remaining countries of the LAMEA region) Next-Generation Sequencing Market All-Up

10. Competitive Landscape Analysis
    10.1. Porter’s Five Forces Analysis
    10.2. Industry – Competitive Landscape
    10.3. Market Presence (Intensity Mapping)
    10.4. Key Strategic Market Developments 

11. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    11.1. Illumina, Inc.
           11.1.1. Company Overview    
           11.1.2. Key Executives 
           11.1.3. Footprint & Employee Strength 
           11.1.4. Product Offerings    
           11.1.5. Financials
           11.1.6. Key Company Developments 
    11.2. Thermo Fisher Scientific, Inc.
           11.2.1. Company Overview    
           11.2.2. Key Executives   
           11.2.3. Footprint & Employee Strength
           11.2.4. Product Offerings
           11.2.5. Financials
           11.2.6. Key Company Developments
    11.3. BGI Group
           11.3.1. Company Overview    
           11.3.2. Key Executives
           11.3.3. Footprint & Employee Strength
           11.3.4. Product Offerings
           11.3.5. Financials
           11.3.6. Key Company Developments
    11.4. PerkinElmer Inc.
           11.4.1. Company Overview    
           11.4.2. Key Executives
           11.4.3. Footprint & Employee Strength
           11.4.4. Product Offerings
           11.4.5. Financials
           11.4.6. Key Company Developments
    11.5. Agilent Technologies, Inc.
           11.5.1. Company Overview    
           11.5.2. Key Executives   
           11.5.3. Footprint & Employee Strength
           11.5.4. Product Offerings
           11.5.5. Financials
           11.5.6. Key Company Developments
    11.6. QIAGEN
           11.6.1. Company Overview    
           11.6.2. Key Executives
           11.6.3. Footprint & Employee Strength
           11.6.4. Product Offerings
           11.6.5. Financials
           11.6.6. Key Company Developments
    11.7. F. Hoffmann-La Roche Ltd.
           11.7.1. Company Overview
           11.7.2. Key Executives
           11.7.3. Footprint & Employee Strength
           11.7.4. Product Offerings
           11.7.5. Financials
           11.7.6. Key Company Developments    
    11.8. Genewiz
           11.8.1. Company Overview
           11.8.2. Key Executives 
           11.8.3. Footprint & Employee Strength
           11.8.4. Product Offerings
           11.8.5. Financials
           11.8.6. Key Company Developments    
    11.9. Agendia
           11.9.1. Company Overview
           11.9.2. Key Executives 
           11.9.3. Footprint & Employee Strength
           11.9.4. Product Offerings
           11.9.5. Financials
           11.9.6. Key Company Developments   
    11.10. Biodesix, Inc.
           11.10.1. Company Overview
           11.10.2. Key Executives 
           11.10.3. Footprint & Employee Strength
           11.10.4. Product Offerings
           11.10.5. Financials
           11.10.6. Key Company Developments   

12. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.

*The list of companies is based on preliminary research in this report, the companies in the final report may change based on research findings.